Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Alpha Tau Medical Ltd. Class A Ordinary Shares
DRTS | US
2.27
USD0.02
0.89%
DRTS | US
About Alpha Tau Medical Ltd. Class A Ordinary Shares
Sector
Healthcare
Industry
Biotechnology
Earnings date
30/06/2024
As of date
21/10/2024
Close
2.27
Open
2.35
High
2.41
Low
2.20
Alpha Tau Medical Ltd. a clinical-stage oncology therapeutics company engages in research development and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin oral pancreatic prostate and breast cancers; and preclinical studies for brain hepatic cell carcinoma glioblastoma multiforme lung cancer and others. The company was incorporated in 2015 and is headquartered in Jerusalem Israel.
View LessDRTS | US
Risk
33.1
Sharpe
-0.87
Luna's Score
61/100
Recommendation
Hold
Luna says (DRTS | US)
What's Working
Strength based on increasing price with high volume
High Current Volume and Positive 1-Day Return
Low Market Beta (-0.4 to 0.8)
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
What's not Working
Microcap (<300M USD)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
30.6%1 month
33.1%3 months
42.5%6 months
57.6%Returns
Fundamental Ratios
PE
-
Fwd. PE
-
Price to book
2.13
Debt to equity
0.17
Debt to assets
0.13
Ent. to EBITDA
-4.77
Ent. to rev.
-
PEG
-
Other Fundamentals
EBITDA
-35.22M
MarketCap
158.73M
MarketCap(USD)
158.73M
Div. yield
-
Op. margin
-
Erngs. growth
-
Rev. growth
-
Ret. on equity
-33.17
Short ratio
1.60
Short perc.
0.08
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bullish (SMA1M > SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
SMAs: Stock Price Trends
Range10D
0.30
Range1M
0.30
Range3M
0.59
Volumes: Market Activity
Rel. volume
2.13
Price X volume
96.18K
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | -4.77 | - | Cheaper |
| Ent. to Revenue | - | - | - |
| PE Ratio | - | 41.03 | - |
| Price to Book | 2.13 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 42.46 | - | Lower Risk |
| Debt to Equity | 0.17 | -1.23 | Expensive |
| Debt to Assets | 0.13 | 0.25 | Cheaper |
| Market Cap | 158.73M | - | Emerging |
